Benchmark Holdings plc

("Benchmark" or "the Company")

Notice of Q3 Results

Presentation for analysts and institutional investors
Equity Development webcast for retail investors
 
Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture
biotechnology business, will announce its Q3 results for the three month period
ended 30 June 2024, on Thursday 22nd August 2024.
 
Presentation for analysts and institutional investors at 08.00 UK time (09.00
CEST)
 
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a presentation for analysts and institutional investors on the
day at 08.00 UK time (09.00 CEST).
 
The presentation will be held in person at Haakon Vlls Gate 2, Oslo, Norway. To
register your interest, please contact benchmark@mhpgroup.com
 
A live webcast of the presentation will be available for analysts and investors
to join remotely at the following link:
https://channel.royalcast.com/landingpage/hegnarmedia/20240822_11/ 
 
Equity Development webcast for retail investors at 12.00 UK time (13.00 CEST)
 
Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial
Officer will host a second webcast for retail investors and wealth managers at
12.00 UK time (13.00 CEST). The webcast is open to all existing and potential
shareholders.
 
To register please visit: 
https://www.equitydevelopment.co.uk/news-and-events/benchmark-investor-presentat
ion-22aug2024 
 
 
 
    Enquiries
For further information, please contact:	
Benchmark Holdings plc	Tel:  0114 240 9939
Trond Williksen, CEO	
Septima Maguire, CFO	
Ivonne Cantu, Investor Relations	
	
	
Deutsche Numis (Nominated Adviser and Broker)	Tel:  020 7260 1000
Freddie Barnfield, Duncan Monteith, Sher Shah	
	
MHP	Tel:  020 3128 8004
Katie Hunt, Reg Hoare	benchmark@mhpgroup.com

 
Equity Development
Hannah Crowe	 
Tel:  020 7065 2692
	
 
 
About Benchmark
Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is
to enable aquaculture producers to improve their sustainability and
profitability.
We bring together biology and technology to develop innovative products and
solutions which improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and nutrition of
their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon
eggs, live feed (Artemia), specialist diets and probiotics and sea lice
treatments. Find out more at www.benchmarkplc.com.